By Editor , 19 September 2026
PhaseWell Research Acquires Austin CNS Trial Site Community Clinical Research

Pittsburgh – September 18, 2026 -- PhaseWell Research has acquired Community Clinical Research (CCR), an Austin, Texas-based inpatient-capable CNS clinical trial site, in a deal advised exclusively by The Braff Group. The transaction gives PhaseWell, a Shore Capital Partners portfolio company headquartered in Nashville, its first inpatient neuropsychiatric research capability.

By Editor , 19 September 2026
Thatch Raises $108M at $1B Valuation as Revenue Grows 7x

San Francisco – September 18, 2026 -- Thatch, a health benefits platform enabling employers to replace group health plans with individual employee budgets, has raised $108 million in new funding at a $1 billion valuation. The round was led by The General Partnership, Index Ventures, General Catalyst, and Andreessen Horowitz, with participation from ADP Ventures, Paychex, Eli Lilly and Company, Scale Venture Partners, QuantumLight, SemperVirens, Quiet Capital, and Avid Ventures.

By Editor , 18 September 2026
Hitachi Energy Commits $528M to Build Mississippi Transformer Plant

Crystal Springs, Mississippi – September 18, 2026 -- Hitachi Energy will build a $528 million transformer manufacturing facility in Gallman, Mississippi, marking the company's largest single U.S. investment to date and pushing its total American manufacturing commitment to roughly $1.5 billion.

By Editor , 18 September 2026
SASE Market Hits $3.5B in Q2 as Branch Refresh Reshapes Growth

Redwood City, Calif. – September 18, 2026 -- The Secure Access Service Edge (SASE) market reached $3.5 billion in the second quarter of 2026, extending year-over-year growth above 20 percent for a fifth consecutive quarter, according to Dell'Oro Group.

By Editor , 18 September 2026
ReEmerge Exits Stealth With $37M Series A for Brain Injury Therapy

Edina, Minn. – September 18, 2026 -- ReEmerge, Inc. has closed an oversubscribed $37 million Series A financing and exited stealth mode to advance a novel therapy targeting chronic cognitive impairment caused by traumatic brain injury (TBI).

By Editor , 18 September 2026
Lindblad Buys Majority Stake in White Desert, Echo Charlie for $61M

New York – September 18, 2026 -- Lindblad Expeditions Holdings, Inc. (NASDAQ: LIND) has acquired a 60% majority stake in White Desert, the Antarctic luxury travel operator, and Echo Charlie, a new aviation adventure brand, for an aggregate cash purchase price of approximately $61 million, plus roughly $6 million for cash on the balance sheet, subject to customary working capital adjustments.

By Editor , 18 September 2026
Axon Plans $1 Billion Zero-Coupon Convertible Notes Offering Due 2031

Scottsdale, Ariz. – September 18, 2026 -- Axon Enterprise, Inc. (Nasdaq: AXON) intends to offer $1.0 billion in aggregate principal amount of 0% convertible senior notes due 2031, subject to market conditions, the public safety technology company announced.

By Editor , 18 September 2026
DISA Uranium to Buy Colorado Assets, Invest $5M in Premier American Uranium

Casper, Wyoming – September 18, 2026 -- DISA Uranium Corporation has agreed to acquire a portfolio of uranium and vanadium projects in Colorado's Uravan Mineral Belt from Premier American Uranium Inc. (TSXV: PUR) (OTCQB: PAUIF) and will simultaneously invest US$5 million in the company, marking its second major U.S. uranium consolidation move this year.